SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation as CEO and CFO Colette Kresss appointment as interim leader dominate discussion. Traders debate whether Nvidia can execute without its founder, with some concerned about leadership and governance risks while others call the selloff an overreaction and buy the dip, citing the companys AI business and upcoming earnings.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Traders are linking SMCIs sharp decline to reports and speculation about DOJ scrutiny involving Super Micro, Nvidia and Megaspeed over alleged chip diversion to China, as well as uncertainty around Nvidia CEO Jensen Huang and SMCIs close Nvidia ties. Some see the move as an overreaction and a buying opportunity; others fear renewed compliance and governance risks.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebiuss quarterly results and outlook are driving attention: despite a revenue beat, investors focused on a delayed capacity ramp, a more cautious near-term revenue outlook, and sharply higher planned capital spending. Traders are split between viewing the selloff as an overreaction given strong demand and customer prepayments, and worrying about execution delays and financing needs; weakness in Nvidia and other AI-linked stocks added pressure.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines stronger-than-expected Q3 resultsalong with record backlog, positive free cash flow, and reaffirmed growth guidanceare driving the rally and bullish re-rating discussion. Traders are also debating whether the gains can hold, citing continuing operating losses and the need to convert backlog into sustained cash generation, while some speculate about short covering.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Jensen Huangs resignation and Nvidias leadership upheaval have fueled a rotation into AMD as traders speculate that customers, investment, or talent could shift toward chip rivals. The community is divided over whether the rally signals lasting market-share gains or is a temporary sympathy move, with some also warning that AMDs valuation is stretched.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

Cardinals Q3 resultsrapid revenue growth overshadowed by sharply compressed margins, a net loss, and withdrawal of its full-year outlookhave fueled a severe selloff; the Hughes Brothers acquisition was also postponed. Traders are split between blaming execution and management credibility, and viewing the decline as excessive given the companys cash position and authorized buyback.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is under pressure amid trader concerns that reported links to Megaspeed, a firm tied to allegations involving Nvidia CEO Jensen Huang, could draw scrutiny or tighter U.S. controls on advanced-chip access to China; Alibabas direct involvement remains unconfirmed. The community is split between seeing the selloff as an overreaction and fearing restricted Nvidia-chip access could hurt Alibabas AI and cloud competitiveness.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp gold selloff tied in community discussion to hotter-than-expected inflation, rising Treasury yields and a stronger dollar, which have revived expectations of tighter Fed policy and weighed on non-yielding bullion. Traders are split between calling the decline a buying opportunity or expecting more downside, with some arguing longer-term demand for gold remains supportive.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Blacklift rocket unveiling and plans to bring launch capability in-house are driving discussion, with bulls seeing a way to reduce reliance on outside launch providers. Skeptics question the rockets timeline, added spending and execution risk while BlueBird deployments and commercial service remain delayed; traders also point to elevated short interest.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas quarterly results beat expectations, with higher revenue guidance, a larger backlog and an earlier adjusted EBITDA break-even timeline driving bullish reactions. The stocks weak response has sharpened debate over compressed gross margins, cash burn and dilution, while some traders blame short selling or broader market pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Five Developments Investors Need to Watch

Recent developments at Lakewood-Amedex Biotherapeutics (NASDAQ:LABT), Kraig Biocraft Laboratories (OTCQB:KBLB), NetClass Technology (NASDAQ:NTCL), Zeta Network Group (NASDAQ:ZNB) and The Children's Place (NASDAQ:PLCE) illustrate very different market stories.

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session.
ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of theirread more...

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption

Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock Redemption Lakewood-Amedex Biotherapeutics Announces Completion of Series C Convertible Preferred Stock RedemptionPR NewswireSARASOTA, Fla., Nov. 5, 2026 SARASOTA, Fla., Nov. 5, 2026 /PRNewswire...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session.
Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6 billion. Asread more...

Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape

From Insulin Management To Cell Replacement: The Diabetes Revolution Is Accelerating   New York, NY – October 7, 2026 – Diabetes cell therapy is moving into a very different phase. For years, the idea of replacing damaged or lost insulin-producing cells sounded more like a long-term scientific goal than a practical treatment strategy. That is […]
The post Diabetes Cell Therapy Enters a New Era as Billion-Dollar Market Opportunity Takes Shape appeared first on Financial News Media.

Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin Compounds

Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin Compounds Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin...

Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences

Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences Lakewood-Amedex Biotherapeutics Announces Participation in October ConferencesPR NewswireSARASOTA, Fla., Oct. 1, 2026SARASOTA, Fla., Oct. 1, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics, Inc. (NASDAQ: LABT, the...

LABT’s Nu-3 Takes Aim at Resistant Foot Infections as Phase 2 Catalyst Looms

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) is heading deeper into the clinical stage with its lead antimicrobial candidate Nu-3, and fresh laboratory data are giving the company another potential catalyst as its Phase 2a trial gets underway.

Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers

Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot UlcersPR NewswireSARASOTA, Fla., Sept. 28, 2026 Lead...

Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers

Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot UlcersPR NewswireSARASOTA, Fla., Sept. 24...

Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.

Lakewood-Amedex Biotherapeutics Inc.

This Newly Listed Biotech Is Soaring – Retail Says $14 Is The Line In The Sand

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Lakewood-Amedex Biotherapeutics Chairman Doug Manion said the listing will enable the company to accelerate the development of its bisphosphocin class of compounds.</li><li>This includes the company’s lead product, Nu-3, which is being developed as a potential treatment for infected diabetic foot ulcers.</li><li>Lakewood-Amedex Biotherapeutics CEO Kelvin Cooper stated that the company plans to initiate a Phase 2a clinical trial of Nu-3 for the treatment of iDFU.</li></ul>Shares of Lakewood-Amedex Biotherapeutics Inc. (LABT) soared more than 70% in Friday’s pre-market trade, a day after the company announced a direct listing on the Nasdaq stock exchange.Lakewood-Amedex Biotherapeutics began trading on the Nasdaq on Thursday, closing the day up over 8% and with a market capitalization of $122 million.<a href="https://stocktwits.com/symbol/LABT">Lakewood-Amedex Biotherapeutics shares</a> were up nearly 50% in Friday’s pre-market trade.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits around the company trended in the ‘neutral’ territory, with message volumes at ‘extremely high’ levels. LABT was among the top-trending tickers on the platform at the time of writing.One user stated that the real test for LABT would be how it handles the $14 level on any pullback today would be the real test for the stock.<stembedurl>https://stocktwits.com/Olivia_Strickland/message/651253709</stembedurl><h2 class="st-heading-2">Chairman Says Listing Will Accelerate Development</h2>Lakewood-Amedex Biotherapeutics Chairman Doug Manion said the listing will enable the company to accelerate the development of its bisphosphocin class of compounds.This includes the company’s lead product, Nu-3, which is being developed as a potential treatment for infected diabetic foot ulcers (iDFU).Lakewood-Amedex Biotherapeutics CEO Kelvin Cooper stated that the company plans to initiate a Phase 2a clinical trial of Nu-3 for the treatment of iDFU.Cooper added that of the 40 million diabetes patients in the U.S., around one-third develop DFU in their lifetime. He stated that the DFU will become infected in around half of these patients.“Numerous patients experience more than one of these events in their life, and antibiotic-resistant bacterial strains are a major concern for the treatment of these patients. We look forward to accelerating our work targeting this major unmet need,” Cooper added.<h2 class="st-heading-2">Early Exploratory Trials Showed No Safety Concerns, Says Company</h2>The company stated that early exploratory trials of Nu-3 at subclinical doses showed no safety concerns, while indicating a trend toward antimicrobial activity and improved wound healing.Based on these findings, the company plans to initiate a Phase 2a study to assess safety and dose response, followed by a placebo-controlled Phase 2b trial comparing different doses.The program will also evaluate the optimal administration regimen for Nu-3 gel formation in mildly infected diabetic foot ulcers, the company said.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dan-ives-intel-comeback-rocky-balboa-ai-trade-in-third-innings/cZBWzYEReTv">Dan Ives Compares Intel's Comeback To Rocky Balboa, Says AI Trade Is In Its Third Innings — 'You Follow The Capex, That's Where Investors Are'</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

“We are pleased to have settled our lawsuit with the United States Department of Justice,” the LYV said in a statement as its stock closed higher. 

Lakewood-Amedex Biotherapeutics started trading on the Nasdaq on Thursday, closing the day with gains of over 8% and a market capitalization of $122 million.

LABT Stock Soars 50% After Nasdaq Debut – Retail Says $14 Is The Line In The Sand

Nvidia ($NVDA) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Stocktwits

) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Current Price	$0.3714
Prev Close	$0.395
Open	$0.3651
Dividend Yield	N/A
50-Day Moving Average	$1.06
Beta	-1.99
Avg. Volume	3.94M
PE Ratio	-0.04

52-Week High	$98.20
52-Week Low	$0.1687
Market Capitalization	$936,027.00
EPS (Annual)	-$8.40
Price to Book	0.20
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

LABT Fundamentals